USH2C Research
Gene: ADGRV1/VLGR1/GPR98
Year Identified: 2004
Each research project listed below will include a graphic of the research continuum. The gold box indicates where this project falls on the continuum, illustrating its progress towards reaching people living with Usher syndrome, from "Bench to Bedside."
Click here to learn more about the different stages in the research continuum.
Gene Therapy USH2C
Erwin van Wijk, Ph.D.; Erik de Vrieze, Ph.D.; and Ronald Pennings, M.D. Ph.D.
Radboud University Medical Center
Drs. Erwin van Wijk, Erik de Vriezer, and Ronald Pennings have received a €250,000 grant from CUREUsher and Stichting Ushersyndroom to complete a research study focusing on minigene therapy as a possible treatment for USH2C. Due to the large funding this project is receiving it will guarantee this study will be completed within its timeframe of four years. The USH2C project follows a similar research study, minigene therapy as a possible treatment for USH2A, with the final results expected to be released in early 2020.
Press Release from CUREUsher
